US Bancorp’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Buy |
4,298
+218
| +5% | +$5.31K | ﹤0.01% | 2398 |
|
|
2025
Q1 | $84.7K | Sell |
4,080
-1,630
| -29% | -$33.8K | ﹤0.01% | 2462 |
|
|
2024
Q4 | $134K | Sell |
5,710
-921
| -14% | -$21.7K | ﹤0.01% | 2243 |
|
|
2024
Q3 | $170K | Sell |
6,631
-1,278
| -16% | -$32.7K | ﹤0.01% | 2114 |
|
|
2024
Q2 | $186K | Buy |
7,909
+790
| +11% | +$18.5K | ﹤0.01% | 2042 |
|
|
2024
Q1 | $205K | Buy |
7,119
+620
| +10% | +$17.8K | ﹤0.01% | 1997 |
|
|
2023
Q4 | $213K | Buy |
6,499
+6,380
| +5,361% | +$209K | ﹤0.01% | 1975 |
|
|
2023
Q3 | $3.32K | Hold |
119
| – | – | ﹤0.01% | 3534 |
|
|
2023
Q2 | $4.06K | Sell |
119
-570
| -83% | -$19.4K | ﹤0.01% | 3504 |
|
|
2023
Q1 | $20.7K | Sell |
689
-798
| -54% | -$24K | ﹤0.01% | 2960 |
|
|
2022
Q4 | $42K | Sell |
1,487
-200
| -12% | -$5.65K | ﹤0.01% | 2621 |
|
|
2022
Q3 | $55K | Buy |
1,687
+200
| +13% | +$6.52K | ﹤0.01% | 2469 |
|
|
2022
Q2 | $47K | Hold |
1,487
| – | – | ﹤0.01% | 2610 |
|
|
2022
Q1 | $68K | Buy |
1,487
+110
| +8% | +$5.03K | ﹤0.01% | 2453 |
|
|
2021
Q4 | $84K | Sell |
1,377
-3,310
| -71% | -$202K | ﹤0.01% | 2375 |
|
|
2021
Q3 | $350K | Sell |
4,687
-115
| -2% | -$8.59K | ﹤0.01% | 1692 |
|
|
2021
Q2 | $444K | Sell |
4,802
-300
| -6% | -$27.7K | ﹤0.01% | 1606 |
|
|
2021
Q1 | $453K | Buy |
5,102
+2,838
| +125% | +$252K | ﹤0.01% | 1554 |
|
|
2020
Q4 | $211K | Buy |
+2,264
| New | +$211K | ﹤0.01% | 1846 |
|